Home > Riviste > La Rivista Italiana della Medicina di Laboratorio > Fascicoli precedenti > Articles online first > La Rivista Italiana della Medicina di Laboratorio 2020 May 08

ULTIMO FASCICOLO
 

JOURNAL TOOLS

eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo

 

 

La Rivista Italiana della Medicina di Laboratorio 2020 May 08

DOI: 10.23736/S1825-859X.20.00059-6

Copyright © 2020 EDIZIONI MINERVA MEDICA

lingua: Italiano

Come distinguere una buona decisione (medica) da una cattiva?

Joseph WATINE

Laboratoire de Biologie Médicale, Centre Hospitalier, Villefranche-de-Rouergue Cedex, France


PDF


The Monitor discusses the concepts of benefits-to-harms and benefits-to-risks ratios in Medicine and the uncertainty for a “true” definition of them, on the basis of the concept of evidence (with its biases and limits) and of the judgments about the pieces of evidence (depending on knowledge, values, beliefs of both physicians and patients) offered by Evidence-based Medicine. Moreover, for a proposal of a general rule for defining good or bad a medical decision, understanding both the individual decisional autonomy and the human community equity is needed.


KEY WORDS: Benefits-to-harms ratio; Evidence-based Medicine; Patient autonomy; Equity

inizio pagina